Answer
Renal impairment does not substantially change its pharmacokinetics, although severe impairment warrants clinical monitoring. Use is not recommended in severe hepatic impairment.
Sources for this answer
- Rizmoic 200 micrograms film-coated tabletsemc · SmPC Current selected SmPC · Version 5